HIV Infections Clinical Trials in Dallas, Texas

4 studies are recruiting for hiv infections in Dallas, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention

    The goal of this observational study is to generate real-life information on the use of lenacapavir (LEN, YEZTUGO®, (YTG)) for pre-exposure prophylaxis (PrEP) across diverse clinical settings in the United States. The study will characterize how PrEP is initiated, used, and discontinued in routine …

    Stage
    Not phased
    Ages
    18 and older
    Site
    Abounding Prosperity Inc., Dallas, Texas
    Locations
    38 in total
    Run by
    Gilead Sciences

    See if you can join NCT07473778 on ClinicalTrials.gov

  2. A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed

    This study compares the efficacy, safety and tolerability of CAB ULA and RPV ULA administered with CAB long acting (LA) and RPV LA administered in adults and adolescents with HIV who are virologically suppressed on anti-retroviral therapy (ART).

    Stage
    Phase 3
    Ages
    12 and older
    Site
    GSK Investigational Site, Dallas, Texas
    Locations
    88 in total
    Run by
    ViiV Healthcare

    See if you can join NCT07650916 on ClinicalTrials.gov

  3. Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy

    The goal of this clinical study is to compare how effective a long-acting injectable treatment of lenacapavir (LEN), teropavimab (TAB), and zinlirvimab (ZAB) versus (CAB) and rilpivirine (RPV) injections given every 8 weeks in adults with HIV-1 whose virus is well controlled on daily oral treatment…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    North Texas Infectious Diseases Consultants, P.A., Dallas, Texas
    Locations
    19 in total
    Run by
    Gilead Sciences

    See if you can join NCT07682961 on ClinicalTrials.gov

  4. A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)

    This clinical study is testing a new medication, VH4524184, to see if it can effectively treat HIV-1 in adults who have never received treatment for their infection. The study is comparing two different doses of VH4524184, each taken with the medications emtricitabine and tenofovir alafenamide (FTC…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    GSK Investigational Site, Dallas, Texas
    Locations
    123 in total
    Run by
    ViiV Healthcare

    See if you can join NCT07202546 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.